CIRRX
Price
$17.51
Change
-$0.06 (-0.34%)
Updated
Oct 8 closing price
Net Assets
8.35B
IARAX
Price
$16.65
Change
-$0.07 (-0.42%)
Updated
Oct 8 closing price
Net Assets
693.72M
Interact to see
Advertisement

CIRRX vs IARAX

Header iconCIRRX vs IARAX Comparison
Open Charts CIRRX vs IARAXBanner chart's image
Cohen & Steers Real Estate Securities R
Price$17.51
Change-$0.06 (-0.34%)
VolumeN/A
Net Assets8.35B
Invesco Real Estate A
Price$16.65
Change-$0.07 (-0.42%)
VolumeN/A
Net Assets693.72M
CIRRX vs IARAX Comparison Chart in %
View a ticker or compare two or three
VS
CIRRX vs. IARAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRRX is a Buy and IARAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 8.35B vs. IARAX (694M). CIRRX pays higher dividends than IARAX: CIRRX (2.37) vs IARAX (1.92). CIRRX was incepted earlier than IARAX: CIRRX (11 years) vs IARAX (29 years). IARAX (1.38) is less costly to investors than CIRRX (1.25). IARAX is a more actively managed with annual turnover of: 63.00 vs. CIRRX (35.00). CIRRX has a lower initial minimum investment than IARAX: CIRRX (0) vs IARAX (1000). CIRRX annual gain was more profitable for investors over the last year : -2.00 vs. IARAX (-6.35). CIRRX return over 5 years is better than : 26.81 vs. IARAX (-0.82).
CIRRXIARAXCIRRX / IARAX
Total Expense Ratio1.251.3891%
Annual Report Gross Expense Ratio1.251.3891%
Fund Existence11 years29 years-
Gain YTD4.1880.707592%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.35B694M1,204%
Annual Yield % from dividends2.371.92123%
Returns for 1 year-2.00-6.3532%
Returns for 3 years32.196.29512%
Returns for 5 years26.81-0.82-3,261%
Returns for 10 years54.80-25.77-213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NECCX14.820.02
+0.14%
Natixis US Equity Opportunities C
JFNSX70.08N/A
N/A
Janus Henderson Global Life Sciences S
VMCPX396.31N/A
N/A
Vanguard Mid Cap Index InstitutionalPlus
BGLAX14.91N/A
N/A
Brookfield Global Listed InfrastructureA
BRWRX27.40N/A
N/A
MFS Blended Research Growth Eq R1